| GeneLibs

题目:: Hepatobiliary cancers, version 2.2014.
作者:: Benson(Al B),D'Angelica(Michael I),Abrams(Thomas A),Are(Chandrakanth),Bloomston(P Mark),Chang(Daniel T),Clary(Bryan M),Covey(Anne M),Ensminger(William D),Iyer(Renuka),Kelley(R Kate),Linehan(David),Malafa(Mokenge P),Meranze(Steven G),Park(James O),Pawlik(Timothy),Posey(James A),Scaife(Courtney),Schefter(Tracey),Sigurdson(Elin R),Tian(G Gary),Vauthey(Jean-Nicolas),Venook(Alan P),Yen(Yun),Zhu(Andrew X),Hoffmann(Karin G),McMillian(Nicole R),Sundar(Hema)
状态:: 发布时间2014-08-07 , 更新时间 2016-10-25
期刊:: J Natl Compr Canc Netw
摘要:: Hepatobiliary cancers include a spectrum of invasive carcinomas arising in the liver (hepatocellular carcinoma), gall bladder, and bile ducts (cholangiocarcinomas). Gallbladder cancer and cholangiocarcinomas are collectively known as biliary tract cancers. Gallbladder cancer is the most common and aggressive type of all the biliary tract cancers. Cholangiocarcinomas are diagnosed throughout the biliary tree and are typically classified as either intrahepatic or extrahepatic cholangiocarcinoma. Extrahepatic cholangiocarcinomas are more common than intrahepatic cholangiocarcinomas. This manuscript focuses on the clinical management of patients with gallbladder cancer and cholangiocarcinomas (intrahepatic and extrahepatic).
语言:: eng
DOI:

文献库文献相关信息